Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

The nature of the work puts these doctors at the center of complex ethical issues, especially when it comes to end-of-life ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

The partnership will enhance the clinic’s ability to provide specialized respiratory care and reinforce its commitment to ...

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Our program provides pulmonary and critical care medicine training in a collaborative environment, to include a unique blend of clinical training and clinical-and-laboratory-based research. Our goal ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...